SCHEMBL2440066

SCHEMBL2440066

CC(C)(C)OC(=O)N1CC[C@H](O)[C@H]1[C@@H](C[N+](=O)[O-])c1c[nH]c2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.39
POLB P06746 2/20 0.39
HDAC3 O15379 2/20 0.37
HDAC4 P56524 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC7 Q8WUI4 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC10 Q969S8 2/20 0.37
HDAC11 Q96DB2 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
HDAC9 Q9UKV0 2/20 0.37
HDAC5 Q9UQL6 2/20 0.37
SSTR2 P30874 3/20 0.35
HTR3E A5X5Y0 2/20 0.35
HTR3B O95264 2/20 0.35
HTR3A P46098 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12299495 1.00 MAPT (0.43) MAPTNPSR1KMT2AMEN1POLB
SCHEMBL12329636 0.87 KMT2A (0.42) KMT2AMEN1POLBHDAC3HDAC4
SCHEMBL12299497 0.87 MAPT (0.39) MAPTNPSR1KMT2AMEN1POLB
SCHEMBL2437115 0.87 MAPT (0.39) MAPTNPSR1KMT2AMEN1POLB
SCHEMBL2443811 0.86 MAPT (0.39) MAPTNPSR1KMT2AMEN1POLB
SCHEMBL2441526 0.86 MAPT (0.39) MAPTNPSR1KMT2AMEN1POLB
SCHEMBL12329376 0.86 KMT2A (0.41) MAPTKMT2AMEN1POLBHDAC3
SCHEMBL12329377 0.86 KMT2A (0.41) MAPTKMT2AMEN1POLBHDAC3
SCHEMBL13448819 0.80 ABCB1 (0.42) MAPTSSTR2CYP3A4CYP2D6LMNA
SCHEMBL2440589 0.80 ABCB1 (0.42) MAPTSSTR2CYP3A4CYP2D6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399683-B2 IAP inhibitors TETRALOGIC PHARMACEUTICALS (US) 2013-03-19 US disclosed
US-20110237517-A1 IAP INHIBITORS TETRALOGIC PHARMACEUTICALS CORP. 2011-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237517-A1 IAP INHIBITORS XIAP, IAPP, BIRC5 MAPT 375/4885NPSR1 3855/4885KMT2A 4485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.